COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP
Product details
Registration number: SIN06429P
Classification: General Sale List
Active ingredients:
- CALCIUM CHLORIDE
- POTASSIUM CHLORIDE
- SODIUM CHLORIDE
- SODIUM LACTATE
Strength:
- 0.027 g/100 ml
- 0.04 g/100 ml
- 0.6 g/100 ml
- 0.312 g/100 ml
Dosage form: INJECTION
Route: INTRAVENOUS
Registrant: B. BRAUN SINGAPORE PTE LTD
ATC code: B05XA30
HSA approval date: 8 July 1991
Manufacturer(s):
- B BRAUN MEDICAL INDUSTRIES SDN BHD
- B. Braun Melsungen AG
- B. Braun Medical SA
Manufacturing country/countries: SPAIN; MALAYSIA; GERMANY
What are the HSA registration number and classification for COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN06429P
Classification: General Sale List
What active ingredients and strength are recorded for COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- CALCIUM CHLORIDE
- POTASSIUM CHLORIDE
- SODIUM CHLORIDE
- SODIUM LACTATE
Strength:
- 0.027 g/100 ml
- 0.04 g/100 ml
- 0.6 g/100 ml
- 0.312 g/100 ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: INTRAVENOUS
Who is the recorded registrant for COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP?
According to the HSA dataset updated 7 August 2026:
Registrant: B. BRAUN SINGAPORE PTE LTD
Which manufacturers and countries are listed for COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- B BRAUN MEDICAL INDUSTRIES SDN BHD
- B. Braun Melsungen AG
- B. Braun Medical SA
Manufacturing country/countries: SPAIN; MALAYSIA; GERMANY
Where can I look up COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN06429P or the exact product name COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP. The general register link does not preselect this product.
What are the source dates for this COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this COMPOUND SODIUM LACTATE INTRAVENOUS INFUSION BP record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN06429P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)